LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
Holding LENZ?
Track your performance easily

LENZ Therapeutics (LENZ) Financial Statements

148 Followers

LENZ Therapeutics Financial Overview

LENZ Therapeutics's market cap is currently ―. The company's EPS TTM is $-9.443; its P/E ratio is -2.96; LENZ Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.25M$ -16.09M$ -22.92M$ -22.48M$ -55.31M
EBITDA$ -9.96M$ -16.08M$ -17.81M-$ -55.37M
Net Income Common Stockholders$ -10.25M$ -16.65M$ -22.92M$ -22.48M$ -55.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 196.11M$ 213.28M$ 184.26M$ 233.99M$ 246.66M
Total Assets$ 202.64M$ 217.32M$ 188.46M$ 266.23M$ 287.02M
Total Debt$ 1.05M$ 156.00K$ 362.00K$ 53.10M$ 53.50M
Net Debt$ -195.06M$ -213.12M$ -183.90M$ -180.89M$ -193.16M
Total Liabilities$ 9.72M$ 19.16M$ 4.87M$ 62.21M$ 62.86M
Stockholders Equity$ 192.92M$ 198.17M$ 183.58M$ 204.02M$ 224.10M
Cash Flow-
Free Cash Flow$ -15.93M$ -23.94M$ -45.25M-$ -18.93M
Operating Cash Flow$ -15.79M$ -23.94M$ -45.88M$ -9.40M$ -13.65M
Investing Cash Flow$ -98.39M$ 18.00M$ 47.08M$ 63.88M$ 72.23M
Financing Cash Flow$ -2.14M$ 171.27M$ 66.00K$ 8.00K$ 124.00K
Currency in USD

LENZ Therapeutics Earnings and Revenue History

LENZ Therapeutics Debt to Assets

LENZ Therapeutics Cash Flow

LENZ Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis